Click here to get full coverage on Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat

Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd  MarketBeat

Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat

Click here to get full coverage on Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Nasdaq

Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect?  Nasdaq

Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Nasdaq

Click here to get full coverage on Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32%  simplywall.st

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st

Click here to get full coverage on Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX - MarketBeat

Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX  MarketBeat

Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX - MarketBeat

Click here to get full coverage on Stifel Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛

Stifel Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $15  富途牛牛

Stifel Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $15 - 富途牛牛

Click here to get full coverage on Can Tango Therapeutics Stock Hold Up When Markets Turn? - Trefis

Can Tango Therapeutics Stock Hold Up When Markets Turn?  Trefis

Can Tango Therapeutics Stock Hold Up When Markets Turn? - Trefis

Click here to get full coverage on Tango Therapeutics (NASDAQ: TNGX) to join Jefferies Healthcare Conf. Nov. 19; 90-day replay - Stock Titan

Tango Therapeutics (NASDAQ: TNGX) to join Jefferies Healthcare Conf. Nov. 19; 90-day replay  Stock Titan

Tango Therapeutics (NASDAQ: TNGX) to join Jefferies Healthcare Conf. Nov. 19; 90-day replay - Stock Titan

Click here to get full coverage on Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy (TNGX) - Seeking Alpha

Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy (TNGX)  Seeking Alpha

Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy (TNGX) - Seeking Alpha

Click here to get full coverage on Stifel Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendation - Nasdaq

Stifel Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendation  Nasdaq

Stifel Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendation - Nasdaq

Click here to get full coverage on Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: What To Expect  Yahoo Finance

Tango Therapeutics Inc (TNGX) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Click here to get full coverage on How Does Tango Therapeutics’ (TNGX) New Equity Move Shape Its Funding Strategy? - simplywall.st

How Does Tango Therapeutics’ (TNGX) New Equity Move Shape Its Funding Strategy?  simplywall.st

How Does Tango Therapeutics’ (TNGX) New Equity Move Shape Its Funding Strategy? - simplywall.st

Click here to get full coverage on Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX - MarketBeat

Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX  MarketBeat

Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX - MarketBeat

Click here to get full coverage on Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price - Yahoo Finance

Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price  Yahoo Finance

Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price - Yahoo Finance

Click here to get full coverage on Tango Therapeutics (TNGX): Evaluating Valuation Following New Shelf Registration and $100 Million Equity Offering - simplywall.st

Tango Therapeutics (TNGX): Evaluating Valuation Following New Shelf Registration and $100 Million Equity Offering  simplywall.st

Tango Therapeutics (TNGX): Evaluating Valuation Following New Shelf Registration and $100 Million Equity Offering - simplywall.st

Click here to get full coverage on Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock?  Yahoo Finance

Tango Therapeutics (TNGX) Soars 7.8%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue - Yahoo Finance

How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue  Yahoo Finance

How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue - Yahoo Finance

Click here to get full coverage on Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why - Yahoo Finance

Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why  Yahoo Finance

Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why - Yahoo Finance

Click here to get full coverage on Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates  Yahoo Finance

Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates  Yahoo Finance

Tango Therapeutics, Inc. (TNGX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - Yahoo Finance

Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last?  Yahoo Finance

Tango Therapeutics (TNGX) Moves 7.5% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?  Yahoo Finance

Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Click here to get full coverage on Tango Therapeutics Inc. (TNGX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Tango Therapeutics Inc. (TNGX) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

Tango Therapeutics Inc. (TNGX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on TNGX Stock Price and Chart — NASDAQ:TNGX - TradingView

TNGX Stock Price and Chart — NASDAQ:TNGX  TradingView

TNGX Stock Price and Chart — NASDAQ:TNGX - TradingView

Click here to get full coverage on Tango Therapeutics (NASDAQ: TNGX) prices equity offering and PIPE for $225M total - Stock Titan

Tango Therapeutics (NASDAQ: TNGX) prices equity offering and PIPE for $225M total  Stock Titan

Tango Therapeutics (NASDAQ: TNGX) prices equity offering and PIPE for $225M total - Stock Titan

Click here to get full coverage on Tango Therapeutics, Inc. (NASDAQ:TNGX) Investors Are Less Pessimistic Than Expected - simplywall.st

Tango Therapeutics, Inc. (NASDAQ:TNGX) Investors Are Less Pessimistic Than Expected  simplywall.st

Tango Therapeutics, Inc. (NASDAQ:TNGX) Investors Are Less Pessimistic Than Expected - simplywall.st

Click here to get full coverage on Guggenheim Maintains Tango Therapeutics (TNGX) Buy Recommendation - Nasdaq

Guggenheim Maintains Tango Therapeutics (TNGX) Buy Recommendation  Nasdaq

Guggenheim Maintains Tango Therapeutics (TNGX) Buy Recommendation - Nasdaq

Click here to get full coverage on Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported Earnings, And Analysts Cut Their Target Price  Yahoo Finance

Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Click here to get full coverage on Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat

Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX  MarketBeat

Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat

Click here to get full coverage on Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages  MarketBeat

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Click here to get full coverage on $TNGX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

$TNGX stock is up 9% today. Here's what we see in our data.  Quiver Quantitative

$TNGX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on New Analyst Forecast: $TNGX Given $12.0 Price Target - Quiver Quantitative

New Analyst Forecast: $TNGX Given $12.0 Price Target  Quiver Quantitative

New Analyst Forecast: $TNGX Given $12.0 Price Target - Quiver Quantitative

Click here to get full coverage on Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely? - Yahoo Finance

Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely?  Yahoo Finance

Will Tango Therapeutics (NASDAQ:TNGX) Spend Its Cash Wisely? - Yahoo Finance

Click here to get full coverage on Insider Sale: 10% owner at $TNGX Sells 477,401 Shares - Quiver Quantitative

Insider Sale: 10% owner at $TNGX Sells 477,401 Shares  Quiver Quantitative

Insider Sale: 10% owner at $TNGX Sells 477,401 Shares - Quiver Quantitative

Click here to get full coverage on First clinical data: TNG260 — Tango Therapeutics presents Phase 1/2 results at SITC Nov 7 - Stock Titan

First clinical data: TNG260 — Tango Therapeutics presents Phase 1/2 results at SITC Nov 7  Stock Titan

First clinical data: TNG260 — Tango Therapeutics presents Phase 1/2 results at SITC Nov 7 - Stock Titan

Click here to get full coverage on Tango Therapeutics Announces Pricing of $210 Million Underwritten Offering and $15 Million PIPE Financing - Quiver Quantitative

Tango Therapeutics Announces Pricing of $210 Million Underwritten Offering and $15 Million PIPE Financing  Quiver Quantitative

Tango Therapeutics Announces Pricing of $210 Million Underwritten Offering and $15 Million PIPE Financing - Quiver Quantitative

Click here to get full coverage on US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results - simplywall.st

US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results  simplywall.st

US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results - simplywall.st

Click here to get full coverage on Tango Therapeutics (NASDAQ: TNGX) posts 7.2-mo mPFS, 25% ORR in 2L MTAP-del pancreatic cancer - Stock Titan

Tango Therapeutics (NASDAQ: TNGX) posts 7.2-mo mPFS, 25% ORR in 2L MTAP-del pancreatic cancer  Stock Titan

Tango Therapeutics (NASDAQ: TNGX) posts 7.2-mo mPFS, 25% ORR in 2L MTAP-del pancreatic cancer - Stock Titan

Click here to get full coverage on TNGX: Pivotal pancreatic cancer study advances, with strong combo data and cash runway into 2028 - TradingView

TNGX: Pivotal pancreatic cancer study advances, with strong combo data and cash runway into 2028  TradingView

TNGX: Pivotal pancreatic cancer study advances, with strong combo data and cash runway into 2028 - TradingView

Click here to get full coverage on Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week High - Time to Buy? - MarketBeat

Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week High - Time to Buy?  MarketBeat

Tango Therapeutics (NASDAQ:TNGX) Hits New 52-Week High - Time to Buy? - MarketBeat

Click here to get full coverage on Tango Therapeutics stock hits 52-week high at 9.7 USD - Investing.com

Tango Therapeutics stock hits 52-week high at 9.7 USD  Investing.com

Tango Therapeutics stock hits 52-week high at 9.7 USD - Investing.com

Click here to get full coverage on Tango Therapeutics launches $100M at-the-market stock offering - MSN

Tango Therapeutics launches $100M at-the-market stock offering  MSN

Tango Therapeutics launches $100M at-the-market stock offering - MSN

Click here to get full coverage on Is Tango Therapeutics Ready to Rebound? - StocksToTrade

Is Tango Therapeutics Ready to Rebound?  StocksToTrade

Is Tango Therapeutics Ready to Rebound? - StocksToTrade

Click here to get full coverage on Tango (NASDAQ: TNGX) will report third quarter results Nov 4; no conference call - Stock Titan

Tango (NASDAQ: TNGX) will report third quarter results Nov 4; no conference call  Stock Titan

Tango (NASDAQ: TNGX) will report third quarter results Nov 4; no conference call - Stock Titan

Click here to get full coverage on Tango Therapeutics stock falls after $210 million share offering - Investing.com

Tango Therapeutics stock falls after $210 million share offering  Investing.com

Tango Therapeutics stock falls after $210 million share offering - Investing.com

Click here to get full coverage on New Analyst Forecast: $TNGX Given $11.0 Price Target - Quiver Quantitative

New Analyst Forecast: $TNGX Given $11.0 Price Target  Quiver Quantitative

New Analyst Forecast: $TNGX Given $11.0 Price Target - Quiver Quantitative

Click here to get full coverage on Here's Why We're Watching Tango Therapeutics' (NASDAQ:TNGX) Cash Burn Situation - simplywall.st

Here's Why We're Watching Tango Therapeutics' (NASDAQ:TNGX) Cash Burn Situation  simplywall.st

Here's Why We're Watching Tango Therapeutics' (NASDAQ:TNGX) Cash Burn Situation - simplywall.st

Click here to get full coverage on Tango Therapeutics Falls 8% After $225 Mln Financing And Phase 1/2 Data Update - Nasdaq

Tango Therapeutics Falls 8% After $225 Mln Financing And Phase 1/2 Data Update  Nasdaq

Tango Therapeutics Falls 8% After $225 Mln Financing And Phase 1/2 Data Update - Nasdaq

Click here to get full coverage on What Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 30% Share Price Gain Is Not Telling You - 富途牛牛

What Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 30% Share Price Gain Is Not Telling You  富途牛牛

What Tango Therapeutics, Inc.'s (NASDAQ:TNGX) 30% Share Price Gain Is Not Telling You - 富途牛牛

Click here to get full coverage on Why Is Tango Therapeutics Stock Falling Today - Tango Therapeutics (NASDAQ:TNGX) - Benzinga

Why Is Tango Therapeutics Stock Falling Today - Tango Therapeutics (NASDAQ:TNGX)  Benzinga

Why Is Tango Therapeutics Stock Falling Today - Tango Therapeutics (NASDAQ:TNGX) - Benzinga

Click here to get full coverage on What's Behind The Big Stock Moves? VEEV, HBIO, TNGX... - Nasdaq

What's Behind The Big Stock Moves? VEEV, HBIO, TNGX...  Nasdaq

What's Behind The Big Stock Moves? VEEV, HBIO, TNGX... - Nasdaq

Click here to get full coverage on Tango Therapeutics: PRMT5 Data Readout Due In 2025 Is Critical (NASDAQ:TNGX) - Seeking Alpha

Tango Therapeutics: PRMT5 Data Readout Due In 2025 Is Critical (NASDAQ:TNGX)  Seeking Alpha

Tango Therapeutics: PRMT5 Data Readout Due In 2025 Is Critical (NASDAQ:TNGX) - Seeking Alpha

Click here to get full coverage on Tango Therapeutics launches new $100 million at-the-market stock offering - Investing.com

Tango Therapeutics launches new $100 million at-the-market stock offering  Investing.com

Tango Therapeutics launches new $100 million at-the-market stock offering - Investing.com

Click here to get full coverage on Tango Therapeutics Announces $225 Million Financing - GlobeNewswire

Tango Therapeutics Announces $225 Million Financing  GlobeNewswire

Tango Therapeutics Announces $225 Million Financing - GlobeNewswire

Click here to get full coverage on Tango Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Tango Therapeutics Second Quarter 2025 Earnings: Misses Expectations  Yahoo Finance

Tango Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Click here to get full coverage on Tango Therapeutics Announces Preliminary Financial Results - TipRanks

Tango Therapeutics Announces Preliminary Financial Results  TipRanks

Tango Therapeutics Announces Preliminary Financial Results - TipRanks

Click here to get full coverage on Tango Therapeutics announces $225 million financing - The Pharma Letter

Tango Therapeutics announces $225 million financing  The Pharma Letter

Tango Therapeutics announces $225 million financing - The Pharma Letter

Click here to get full coverage on Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights  GlobeNewswire

Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

Click here to get full coverage on Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? - The Motley Fool

Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares?  The Motley Fool

Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? - The Motley Fool

Click here to get full coverage on Tango Therapeutics (TNGX) Q3 2025 Earnings: EPS of $0.14 Beats E - GuruFocus

Tango Therapeutics (TNGX) Q3 2025 Earnings: EPS of $0.14 Beats E  GuruFocus

Tango Therapeutics (TNGX) Q3 2025 Earnings: EPS of $0.14 Beats E - GuruFocus

Click here to get full coverage on Tango Therapeutics stock gains as Cantor Fitzgerald reiterates Overweight rating - Investing.com

Tango Therapeutics stock gains as Cantor Fitzgerald reiterates Overweight rating  Investing.com

Tango Therapeutics stock gains as Cantor Fitzgerald reiterates Overweight rating - Investing.com

Click here to get full coverage on Tango Therapeutics Stock Falls After $210 Million Equity Offering - Tokenist

Tango Therapeutics Stock Falls After $210 Million Equity Offering  Tokenist

Tango Therapeutics Stock Falls After $210 Million Equity Offering - Tokenist

Click here to get full coverage on Major Shareholder Sells Millions in Tango Therapeutics Stock! - TipRanks

Major Shareholder Sells Millions in Tango Therapeutics Stock!  TipRanks

Major Shareholder Sells Millions in Tango Therapeutics Stock! - TipRanks

Click here to get full coverage on Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights  GlobeNewswire

Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

Click here to get full coverage on We Think Tango Therapeutics (NASDAQ:TNGX) Needs To Drive Business Growth Carefully - 富途牛牛

We Think Tango Therapeutics (NASDAQ:TNGX) Needs To Drive Business Growth Carefully  富途牛牛

We Think Tango Therapeutics (NASDAQ:TNGX) Needs To Drive Business Growth Carefully - 富途牛牛

Click here to get full coverage on Tango Therapeutics reports Q3 net income, revenue jumps - TradingView

Tango Therapeutics reports Q3 net income, revenue jumps  TradingView

Tango Therapeutics reports Q3 net income, revenue jumps - TradingView

Click here to get full coverage on Major Stakeholder Sells Off Tango Therapeutics Shares in Multi-Million Dollar Deal - TipRanks

Major Stakeholder Sells Off Tango Therapeutics Shares in Multi-Million Dollar Deal  TipRanks

TNGX

Price Chart

Key Statistics

Technicals

About TNGX

Latest News

Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat

Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Nasdaq

Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st

Advanced Charts

Top Gainers

Top Losers